Option chain shows key data for Inspire Veterinary's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Inspire Veterinary.

Inspire Veterinary (NASDAQ:IVP) Stock, Option Chain

Inspire Veterinary

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADXN

ATNI

BIVI

BOOM

ENSC

GNPX

ALPS ETF Trusthen & Steers Global Realty Majors ETF

INAB

IRTC

KSCP

MEDP

MKTW

NTBL

SNSE

TCBP

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

AUMN

BENF

BMRA

BURU

CCCC

EAST

FEMY

Intelligent Bio Solutions Inc. - Common Stock

INBS

LIFW

MULN

SMMT

SVRA

TNXP

WHLR

Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

movers image

AVGO

BLMZ

BOWL

CLNN

FFIE

GWRE

HOTH

SIFY

SWBI

TDUP

Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Inspire Veterinary Partners, Inc. - Class A Common Stock

Inspire Veterinary Partners Inc

IVANHOE MINES LTD A by Ivanhoe Mines Ltd.

Ivanhoe Mines Ltd

FromSoftware's award-winning Elden Ring is a franchise fans won't need to say goodbye to just yet, but don't expect a <a href="https://www.benzinga.com/general/gaming">direct sequel.</a>
In a recent <a href="https://game.watch.impress.co.jp/docs/interview/1644616.html">interview</a> with Japanese outlet Game Watch, Hidetaka Miyazaki, the studio&#8217;s acclaimed creator, confirmed that Elden Ring 2 is not part of the company&#8217;s plans.
See Also:<a href="https://www.benzinga.com/general/gaming/24/12/42270630/gta-6-fans-analyze-playlists-and-combat-ai-chaos-one-year-after-first-trailer"> GTA 6 Fans Analyze Playlists And Combat AI Chaos, One Year After First Trailer</a>
Speaking after Elden Ring DLC Shadow of the Erdtree earned top honors at this year's PlayStation Awards, Miyazaki clarified the studio's direction. 
&#8220;At this point, we are not considering developments such as &#8220;Elden Ring 2&#8221;, he said. &#8220;However, this does not mean that we are denying the development of the IP &#8216;Elden Ring&#8217;.&#8221; 
He added: &#8220;As for &#8216;what will we do then?&#8217;, FromSoftware is running multiple projects as usual. Among them, there are various variations of projects, so I hope you will look forward to them.&#8221;
<h3 class="wp-block-heading">Speculation: What's Next For FromSoftware?</h3>
Beyond Elden Ring, FromSoftware appears to be juggling a slate of unannounced projects. Earlier this year, now-deleted job listings sparked speculation of a potential new Armored Core installment, with mentions of robot characters fueling the theory. Given the studio's legacy in mecha-themed titles, such a pivot would align with its history of alternating between genres.
Moreover, the studio's parent company Kadokawa has acknowledged <a href="https://www.benzinga.com/general/gaming/24/11/42098643/kadokawa-ceo-confirms-sonys-buyout-interest-no-decision-has-been-made">acquisition interest</a> from Sony Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42141838/elden-ring-creator-hidetaka-miyazaki-teases-various-new-projects-in-development">Elden Ring Creator Hidetaka Miyazaki Teases &#8216;Various New Projects&#8217; In Development</a></li>
</ul>
Image credits: Shutterstock.

Gaming

General

Sony Group Corporation American Depositary Shares

SONY

'We Are Not Considering Elden Ring 2,' Says FromSoftware's Miyazaki

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Aptose Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) with a Buy and maintains $2 price target.

Price Target

Reiteration

Analyst Ratings

APTO

HC Wainwright & Co. Reiterates Buy on Aptose Biosciences, Maintains $2 Price Target

At the recent <a href="https://benzinga.swoogo.com/digital-assets/6342807">Benzinga Future of Digital Assets</a> event, industry leaders tackled how stablecoins are reshaping finance, spurring adoption among institutional investors, and addressing operational hurdles in digital markets. The panel, moderated by BlackRock's Kyle Braden, featured Jennifer O'Rourke of DTCC Digital Assets, Chuck Mounts of S&amp;P Global Ratings, and David Alderman of Franklin Templeton, who provided valuable perspectives.
<h4 class="wp-block-heading">Stablecoins: A Bridge To Institutional Participation</h4>
Mounts described stablecoins as a critical link between traditional finance and the digital asset ecosystem. 
"Stablecoins are&#8230; positioned to be the accelerant to the mass adoption for tradfi firms and crypto financial capabilities in the marketplace," he explained. Mounts shared how S&amp;P Global's stablecoin stability assessment tool is helping institutions evaluate the risk of stablecoins losing their peg to fiat currencies, adding a layer of confidence for new entrants to the market.
Mounts emphasized the need for stablecoins to underpin the tokenization of real-world assets, citing the potential for increased liquidity and operational efficiency. "Policy formation is the single most important non-technology catalyst," he added, predicting that stablecoin legislation could be the first crypto-related law passed by the new Congress.
<h4 class="wp-block-heading">Overcoming Liquidity And Settlement Challenges</h4>
O'Rourke highlighted the practical challenges tied to stablecoin adoption, particularly regarding liquidity pools and settlement speed. She explained that tokenized assets offer fast and programmable transactions, but the supporting payment systems often lag. 
"If you're going to buy a tokenized asset&#8230; you need to be able to pay for it as quickly as you want to receive it," O'Rourke stated. Addressing this disparity, she argued, is essential for widespread adoption.
O'Rourke also touched on the fragmented nature of liquidity in digital markets, where isolated pools make seamless transactions difficult. She stressed the importance of standardizing processes to connect these pools, paving the way for a more cohesive digital marketplace.
<h4 class="wp-block-heading">Regulatory Clarity On The Horizon</h4>
Alderman of Franklin Templeton pointed to recent shifts in U.S. regulation as promising for stablecoins and digital assets. "I think a lot of crypto companies that were thinking about leaving the U.S. will stay, just because now it's a more pro-crypto stance," he said. 
Alderman added that regulatory clarity would encourage companies to invest in new technologies and infrastructure, further supporting the adoption of stablecoins.
Mounts agreed, describing the potential for stablecoin legislation to reduce uncertainty and enable financial institutions to participate more actively in the market. He also noted that stablecoins could play a role in dollarizing foreign economies, citing their use in markets like Argentina as an example.
<h4 class="wp-block-heading">Building A Path Forward</h4>
As the discussion wrapped up, panelists agreed that while stablecoins present challenges, their potential to transform finance is undeniable. The ongoing work to address operational hurdles and regulatory ambiguity will lay the groundwork for broader adoption, making stablecoins a cornerstone of future financial systems.
From their use in tokenizing real-world assets to their potential impact on global markets, stablecoins are proving to be a driving force in bringing digital assets into the institutional fold.
Photo by Igor Faun on Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Events

Exclusives

Interview

'Policy Formation Will Be Critical': Experts Weigh In On Stablecoin Adoption

Decibel Cannabis Company Inc. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DB#TSXV">DB</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/DBCCF#OTCQB">DBCCF</a>) announced Tuesday that it has received final acceptance from the TSX Venture Exchange for its previously announced acquisition of a Canadian licensed producer of cannabis, AgMedica Bioscience Inc.
The acquisition, arranged through an agreement with Callisto Capital Corp. on October 28, 2024, was made in exchange for a <a href="https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance">$6.3 million unsecured convertible debenture</a>. As a result of receiving the acceptance, Decibel has completed the conversion of the convertible debenture, pursuant to which it has issued 114.55 million common shares to Callisto.
The conversion of the convertible debenture was conditional upon receipt of final TSXV acceptance for the acquisition of AgMedica pursuant to Exchange Policy 5.3. This policy would have required approval from disinterested shareholders if Callisto became a major controller of the company. However, because the company has finished its recent private funding, Callisto will not control the company after the bond is converted. Therefore, approval from disinterested shareholders is not needed for the conversion.
Read Also: <a href="https://www.benzinga.com/24/12/42272602/cannabis-retail-giant-high-tide-launches-cabana-club-membership-program-in-us-eu-and-uk-with-new-product-categories">Cannabis Giant High Tide Taps Into $113 Billion Global E-Commerce Market With New Product Categories</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
On Nov. 25, the Calgary, Alberta-based cannabis company confirmed completion of the second and final closing of non-brokered private placement of its common shares at $0.06 per share. At the second closing of the offering, it issued 19.65 million shares for gross proceeds of <a href="https://www.benzinga.com/news/financing/24/11/42164794/decibel-cannabis-raises-1-18m-secures-capital-for-agmedica-bioscience-integration">roughly $1.18 million.</a>
Previously, Decibel projected that AgMedica could <a href="https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance">contribute $30 million of net revenue</a> and $4 million of EBITDA in 2025, totaling an anticipated $130 million of net revenue and $25 million of adjusted EBITDA in 2025 on a pro-forma basis.
The transaction is expected to materially expand Decibel&#8217;s international footprint with EU GMP certification that enables export of flower and a variety of extract products, with proven sales to seven different countries including Australia, Denmark, Germany, Israel, Norway, Spain and the United Kingdom.
Price Action
Decibel shares closed Monday's market session 6.62% higher at $0.0499 per share.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53">Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%</a></li>
<li><a href="https://www.benzinga.com/markets/cannabis/24/12/42280135/health-canada-cuts-14-6m-from-cannabis-program-amid-federal-austerity">Health Canada Cuts $14.6M From Cannabis Program Amid Federal Austerity</a></li>
</ul>
Photo: Courtesy of pashabo&nbsp;via Shutterstock

Cannabis

DBCCF

TSXV:DB

Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion

Goldman Sachs analyst Gustavo Miele initiates coverage on Afya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFYA#NASDAQ">AFYA</a>) with a Sell rating and announces Price Target of $16.

Initiation

AFYA

Goldman Sachs Initiates Coverage On Afya with Sell Rating, Announces Price Target of $16

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATYR#NASDAQ">ATYR</a>) with a Buy and maintains $35 price target.

ATYR

HC Wainwright & Co. Reiterates Buy on aTyr Pharma, Maintains $35 Price Target

Zscaler Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) shares tanked in early trading on Tuesday, even after the company reported <a href="https://www.benzinga.com/news/earnings/24/12/42277443/zscaler-q1-earnings-revenue-beat-eps-beat-new-ai-opportunities-shares-slide">upbeat fiscal first-quarter results</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<ul>
<li>Scotiabank <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f3e8361f1366100014edfce/patrick-colville">analyst Patrick Colville</a> reaffirmed a Sector Outperform rating, while raising the price target from $195 to $205.</li>
<li>JMP Securities <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6298be750c34880001d668d9/trevor-walsh">analyst Trevor Walsh</a> maintained a Market Outperform rating, while lowering the price target from $270 to $240.</li>
<li>BMO Capital Markets <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585beadcb5a482000151d18b/keith-bachman">analyst Keith Bachman</a> reiterated an Outperform rating, while raising the price target from $197 to $222.</li>
<li>Oppenheimer <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5937f6b185b07a0001ac364f/ittai-kidron">analyst Ittai Kidron</a> reiterated an Outperform Buy rating, while lifting the price target from $230 to $250.</li>
<li>RBC Capital Markets <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5880b6f377f9dd00011b0ab2/matthew-hedberg">analyst Matthew Hedberg</a> an Outperform rating and a price target of $230.</li>
<li>Stifel <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6022b60ca6fe6f0001873d54/adam-borg">analyst Adam Borg</a> reiterated a Buy rating and price target of $235.</li>
<li>Needham <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/601a8839a6fe6f00010c6966/mike-cikos">analyst Mike Cikos</a> initiated coverage of Zscaler with a Buy rating and price target of $240.</li>
<li>Guggenheim Securities <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587f78d077f9dd000126ef0f/john-difucci">analyst John DiFucci</a> maintained a Neutral rating on the stock.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Scotiabank: Zscaler's billings rose 13% year-on-year in the fiscal first quarter. The fiscal 2025 guidance was &#8220;no doubt an underwhelming start to the year," Colville said. CFO Remo Canessa's retirement "will add more uncertainty on Zscaler's commitment to its F25 billings target," he added.
The company's profitability in the first quarter was healthy, suggesting "plenty of room to beat and raise through the remainder of the fiscal year," the analyst stated. "While Zscaler is undoubtedly a tough story to love right now, we continue to wholeheartedly believe in our medium-term thesis, that Zscaler is a leader in SASE, a market which is far from saturated," he further wrote.
JMP Securities: Zscaler's quarterly results were healthy "across all guided metrics," Walsh said. Non-GAAP earnings of 77 cents per share came in higher than consensus of 63 cents, while revenues of $628.0 million were ahead of consensus of $606.1 million, he added.
The company's full-year revenue guidance reflects 21% growth, versus 26% year-on-year growth reported for the fiscal first quarter. Canessa&#8217;s retiring after eight years with the company overshadows the quarterly results, Walsh added.
BMO Capital Markets: Zscaler delivered a modest billings beat for the quarter. The company also raised its full-year guide by the amount of the billings beat. Billings growth of 13% year-on-year marks a deceleration from the previous quarter's 27% growth, with a decline in new and upsell billings.
The company reported RPO of $4.41 billion, with 26% year-on-year growth, Bachman said. The retirement of Canessa, 67, seems "appropriate and understandable.&#8221;
Oppenheimer: Zscaler's results were "solid" and better than expected, driven by "growing customer demand for emerging products and large-customer activity," Kidron said. "Mgmt. also highlighted improved sales productivity and lower attrition, supporting improved pipeline generation and customer engagement.&#8221;
The analyst expressed optimism around Zscaler making a strong recovery in the back half of fiscal 2025 and momentum building in fiscal 2026, "as the sales motion matures and emerging products drive expansion." 
Investors could still adopt a "wait-and-see approach." Guidance for the rest of the year remains unchanged. But the CFO transition causes "added uncertainty," he further wrote.
RBC Capital Markets: Zscaler delivered a beat "across the board" that flowed through to the raised guidance, Hedberg said. The results were highlighted by 26% revenue growth 13% billings growth, he added.
The midpoint of the full-year revenue guidance suggests 21.5% growth, while that of billings points to 19.6% growth.
Stifel: Zscaler's quarterly results reflected ongoing demand for the company's "broadening zero-trust portfolio,' Borg said. Elevated expectations exerted pressure on the stock, he added.
Shares traded lower on the news of Canessa&#8217;s retirement. "We think shares likely trade sideways until investors get more confidence in the F2H25 ramp/new CFO," Borg further wrote.
Needham: Zscaler outperformed expectations in the quarter. Upside to billings is being driven by "20%-plus yr-yr growth in Unscheduled Billings (composed of New, Upsell, &amp; Renewal Billings)," Cikos said in the initiation note.
Management raised the full-year guidance only by the first-quarter beat, which is "in keeping with Zscaler&#8217;s typical prudence in guidance-setting," the analyst stated. This suggests that the company is likely to outperform over the remainder of the year, he added.
"We believe continued improvement in attrition, alongside go-to-market efforts can help Zscaler deliver further outperformance through FY25, particularly as new products gain traction," Cikos further wrote.
Guggenheim Securities: There was "significant moderation in business momentum," with billings growth decelerating to 13%, "which was halved from the 27% in the previous quarter," DiFucci said.
The company could achieve 19% billings growth in the first half of the year, provided new and renewal contracts of the last two years "are automatically billed (assuming 3-year deals)," the analyst stated. This could be followed by 25% growth in the second half, he added.
Price Action: Shares of Zscaler had declined by 4.10% to $199.96 at the time of publication on Tuesday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42292203/whats-going-on-with-zscaler-stock-tuesday">What&#8217;s Going On With Zscaler Stock Tuesday?</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings Beats

Zscaler Posts Q1 Beat: 8 Analysts Express Concern Around CFO Retirement, Guidance

<a href="https://www.youtube.com/watch?v=aAqSPkb6XS4" title="https://www.youtube.com/watch?v=aAqSPkb6XS4">https://www.youtube.com/watch?v=aAqSPkb6XS4</a>

U.S President Biden Says U.S. Will Give $1B In Humanitarian Support For Displaced Africans

The National Basketball Association (NBA) has <a href="https://www.benzinga.com/markets/cannabis/23/04/31623072/nba-drops-cannabis-testing-for-players-can-the-nfl-be-far-behind">not been testing players for marijuana use</a> since April 2023. Some questioned the move, while others praised it, including rapper, cannabis entrepreneur and <a href="https://www.benzinga.com/markets/cannabis/23/04/31861662/snoop-dogg-praises-nba-cannabis-testing-policy-change-i-thought-of-the-medical-side-of-it">advocate</a> Snoop Dogg.
Former NBA player Jason Williams, who played from 1998 to 2011, said even if marijuana had been legal during his playing days, he wouldn&#8217;t have used it before games.
Williams admitted he experimented with cannabis during his years in court. However, he didn't believe it made him a better player. Marijuana enhanced his creativity and imagination on the court, Williams said.
&#8220;I don&#8217;t think anyone should probably smoke before a game, Williams <a href="https://www.basketballnetwork.net/off-the-court/jason-williams-would-never-do-pre-game-marijuana-smoking#comments">told</a> Basketball Network. "For some people, it might help them, and I&#8217;m sure it does, but for me, smoking before a game wouldn&#8217;t be a good idea.&#8221;
Comparing marijuana to alcohol, Williams, who is nicknamed &#8220;White Chocolate,&#8221; argued alcohol is &#8220;way worse for an athlete.&#8221; He said marijuana use was less harmful compared to the risks associated with alcohol.
&#8220;After a game or whatnot, you go home and smoke one. It ain&#8217;t like you&#8217;re going to go out to the club, drinking a beer, speeding, or doing DUI things like that,&#8221; Williams said. &#8220;If anybody thinks that marijuana is a performance-enhancing drug, they&#8217;ve never smoked it.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/06/33067306/nbas-historic-agreement-lifts-marijuana-ban-allows-players-to-invest-in-companies">NBA&#8217;s Historic Agreement Lifts Marijuana Ban, Allows Players To Invest In Companies</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">NBA Players Venturing Into Cannabis</h3>
Some NBA players have even ventured into the marijuana industry, launching and operating their own cannabis businesses.
NBA&nbsp;Hall of Famer&nbsp;and sports legend-turned-cannabis entrepreneur <a href="https://www.benzinga.com/topic/isiah-thomas">Isiah Thomas</a> has made his dreams come to life.
The ex-Detroit Piston is CEO and chairman of One World Products Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OWPC#OTC">OWPC</a>), the largest Black-controlled, licensed hemp and cannabis producer in Colombia. One of his missions is to <a href="https://www.benzinga.com/markets/cannabis/23/03/31383033/isiah-thomas-from-nba-champ-to-business-mogul-hemp-cars-cbd-drinks-champagne-producer">produce hemp cars.</a>
According to last year's&nbsp;agreement with Stellantis, one of the largest automakers worldwide and owner of Chrysler, Citroën, Dodge, Fiat, Jeep, Peugeot and other portfolio brands, OWP agreed to develop and supply hemp-based bioplastic components for cars&#8217; interiors and exteriors.
Meanwhile, two-time NBA champion Lamar Odom has teamed up with CBD dispensary Higher Life CBD in 2022 <a href="https://www.benzinga.com/markets/cannabis/22/11/29599049/2x-nba-champion-lamar-odom-becomes-co-owner-of-a-black-owned-cbd-dispensary">becoming a co-owner of the company.</a>
Other NBA players who opted for the same move include <a href="https://www.benzinga.com/markets/cannabis/24/09/40903844/nba-legend-gary-payton-launches-cannabis-recovery-brand-greater-purpose">Gary Payton</a> and <a href="https://www.benzinga.com/markets/cannabis/24/10/41235083/nba-legend-carmelo-anthony-gets-into-cannabis-industry-leveling-playing-field-for-new-operators">Carmelo Anthony</a>, to name a few.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/05/38986022/nfl-players-arrested-for-cannabis-possession-in-kansas-as-biden-reiterates-no-one-should-be-in-j">NFL Players Arrested For Cannabis Possession In Kansas As Biden Reiterates No One Should Be In Jail For Marijuana</a></li>
</ul>

Entrepreneurship

OWPC

NBA Champ Jason Williams Says Marijuana Enhances Creativity On Court But Not 'Good Idea' Before Game

Faraday Future's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NYSE">FFIE</a>) short percent of float has fallen 58.11% since its last report. The company recently reported that it has 7.40 million shares sold short, which is 16.32% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Faraday Future Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733246122_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Faraday Future has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Faraday Future's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Faraday Future's peer group average for short interest as a percentage of float is 7.18%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(FFIE) - Analyzing Faraday Future's Short Interest

Glaukos's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) short percent of float has risen 6.52% since its last report. The company recently reported that it has 2.81 million shares sold short, which is 8.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Glaukos Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733246117_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Glaukos has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Glaukos's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Glaukos's peer group average for short interest as a percentage of float is 3.73%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

GKOS

How Is The Market Feeling About Glaukos?

When Kobe Harris mixed his first batch of lip balm on his bedroom floor in 2019, the thought of dropping out of <a href="https://www.benzinga.com/personal-finance/24/09/40759485/harris-push-for-free-college-vs-trumps-focus-on-workforce-training-which-is-right-for-america">college </a>wasn't part of the plan. But after racking up $15,000 in sales in a single day, Harris knew he was onto something big.
Don't Miss:
<ul>
<li>If you invested $100 in DOGE when Elon Musk first tweeted about it in 2019,<a href="https://www.benzinga.com/money/etoro-doge"> here&#8217;s how much you&#8217;d have today</a>.</li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
The founder of Kobee's, a Las Vegas-based personal care brand, recently shared his journey on ABC's "Shark Tank," revealing how he turned a $200 investment into a booming business.&nbsp;
His product line – lip balms, lotions, lip scrubs, cuticle butter and hand salves – stands out for its simplicity: just four ingredients (beeswax, coconut oil, sunflower oil and mango butter) and eco-friendly, compostable packaging. The company website says prices range from $5 to $42.
The idea was born from a college research project on sustainability and bees while Harris was studying at Loyola University Chicago. "I asked my mom for $200 to buy ingredients on Amazon and started experimenting on my bedroom floor," Harris told Shark Tank's judges. He juggled this early experimentation with a summer job as a lifeguard.
See Also: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest TODAY for just $0.26/share with a $1000 minimum.</a>
By fall, Harris's small operation had gained traction and online classes allowed him to devote more time to his brand. "I told my dad I was still in school, but really, I was in the basement making lip balms," Harris joked.
Fast-forward to 2024 and Kobee's is projected to close the year with nearly $4 million in sales and about $750,000 in profit at the time of the show's recording. The products are sold primarily through Amazon and the company's website, which has a loyal <a href="https://www.benzinga.com/24/11/42116068/most-tesla-semi-customers-have-waited-seven-years-already-will-they-really-have-to-wait-a-full-decade">customer </a>base.
The company's eco-conscious approach is resonating with consumers: According to industry data from Maximize Market Research, the global lip balm market, valued at $892.46 million in 2023, is projected to reach $1.39 billion by 2030. The surge is fueled by growing demand for natural and organic personal care products.
Trending: Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a>
Harris's pitch on Shark Tank sought $300,000 for a 6% stake in his company, aiming to leverage the investors' expertise in scaling distribution.&nbsp;
Most of the judges, however, bowed out. Lori Grenier called the natural lip balm market oversaturated while Daymond John and <a href="https://www.benzinga.com/startups/24/09/41008222/mark-cuban-wants-to-crack-down-on-chinese-knockoffs-says-vice-president-kamala-harris-is-on-board-wi">Mark Cuban</a> said it wasn't the right fit for their portfolios. Guest panelist Kendra Scott admitted she didn't see how she could help.
The lone offer came from Kevin O'Leary, who proposed $300,000 for 20% equity, citing his network of retail connections. Harris countered with 10% and after a brief negotiation, O'Leary dropped to 15%. Harris stood firm, declining the offer.
"I needed to trust my gut," Harris said later, echoing advice from his mother, a seasoned entrepreneur. "I know my business better than anybody."
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

From $200 To $4M: Lip Balm CEO Who Dropped Out Of College Says 'I Know My Business Better Than Anybody'

Coca-Cola's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) short percent of float has risen 9.72% since its last report. The company recently reported that it has 33.66 million shares sold short, which is 0.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.19 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Coca-Cola Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733246111_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Coca-Cola has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Coca-Cola's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Coca-Cola's peer group average for short interest as a percentage of float is 7.93%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Coca-Cola?

The &#8220;American exceptionalism&#8221; trade is making a roaring comeback, fueled by the potential resurgence of &#8220;America First&#8221; policies under the upcoming Trump administration, <a href="https://www.benzinga.com/topic/expert-ideas">according to Bank of America</a>.
Bank of America analyst Ohsung Kwon highlighted Tuesday the sharp rise in the three-month correlation between the S&amp;P 500 and the U.S. dollar, which has surged to its highest level since 2017.
<h1 class="wp-block-heading">Correlation Between U.S. Stocks, Dollar Hits Highest Since 2017</h1>
Since the election, U.S. equities have outperformed international stocks by three percentage points, while the U.S. dollar has appreciated 2.9%, signaling renewed investor confidence in America's economic resilience.
The correlation between international equities and the dollar has declined, creating a spread that reached its second-highest level in history, only behind the spike following Trump's 2016 election victory, the analyst said. 
"The recent strength in the U.S. dollar suggests the U.S. economic outlook is improving relative to other countries, which is also driving U.S. equities higher versus the rest of the world," said Kwon.
Between the 2016 election and the end of 2017, the S&amp;P 500, as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), gained 25%, outperforming international stocks, tracked by the iShares MSCI ACWI EX U.S. ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACWX#NYSE">ACWX</a>), by 7.6 percentage points.
The post-election rally this year — while more modest — still sees the S&amp;P 500 ahead by three percentage points.
<h1 class="wp-block-heading">Chart: U.S. Stocks Sharply Outperform Rest Of The World In 2024</h1>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03110419/image-22-1024x501.png" alt="" class="wp-image-674808" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03110419/image-22-1024x501.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03110419/image-22-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03110419/image-22-768x376.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03110419/image-22-1536x752.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03110419/image-22.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h1 class="wp-block-heading">Jobs Report: The Next Catalyst For Markets?</h1>
The next test for the &#8220;American exceptionalism&#8221; trade could come Friday, with the release of the November employment report. 
Bank of America economist Stephen Juneau said the report will likely be noisy, reflecting temporary factors like the end of the Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) strike and hurricane-related recovery.
BofA expects nonfarm payrolls to jump by 240,000, bolstered by these one-off effects. To get a clearer sense of the labor market's health, Juneau suggested looking at the two-month average of payroll gains.
Adding to the strong labor market narrative, October job openings surprised to the upside. According to the official report released on Tuesday, job openings increased by 372,000 to 7.744 million in October, surpassing market expectations of 7.48 million.
The market reaction to the jobs report may be muted, with S&amp;P options pricing in just an 86-basis-point implied move — the smallest expected reaction since July.
Analysts attribute this to a combination of waning macro volatility. &#8220;Likely a combination of high data volatility, extreme forecasting challenges, and the Fed&#8217;s &#8216;data-dependent&#8217; posture,&#8221; Juneau wrote, adding that the SPY&#8217;s flat reaction to last month&#8217;s surprising inflation data &#8220;was not encouraging&#8221;
Read Next: • <a href="https://www.benzinga.com/24/12/42291861/trumps-tariff-plan-risks-economic-pain-for-north-america-goldman-sachs-warns">Trump&#8217;s Tariff Plan Risks Economic Pain For North America, Goldman Sachs Warns</a>

Photo: Shutterstock

Macro Economic Events

Broad U.S. Equity ETFs

Forex

Global

Econ #s

Economics

Federal Reserve

ETFs

ACWX

'American Exceptionalism Trade' Gains Steam As Dollar, S&P 500 Surge In Lockstep: Bank Of America

Avalanche (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/avax/usd">AVAX</a>) is seeing bullish momentum, fueled by strong fundamentals and <a href="https://www.benzinga.com/money/is-avalanche-avax-a-good-investment">optimistic community sentiment.</a>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Avalanche (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/avax/usd">AVAX</a>)</td>
<td>$50.36</td>
<td>$20.6 billion</td>
<td>+2.9%</td>
<td>+19.3%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$224.32</td>
<td>$106.6 billion</td>
<td>-1.1%</td>
<td>-3.2%</td>
</tr>
<tr>
<td>BNB (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>)</td>
<td>$647.03</td>
<td>$93.2 billion</td>
<td>+0.4%</td>
<td>+4.5%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Pseudonymous crypto trader Kaleo <a href="https://x.com/CryptoKaleo/status/1863429720676651393">predicts</a> a "God candle" to push AVAX beyond $100 this December.
Crypto influencer TrendFI initially anticipated a rally to $65 followed by consolidation but now believes AVAX will surpass $100 sooner than expected.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Initially I was thinking <a href="https://twitter.com/search?q=%24AVAX&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$AVAX</a> would stop at $65 and consolidate for a while. Considering how fast alts are moving, I now think <a href="https://twitter.com/hashtag/AVAX?src=hash&amp;ref_src=twsrc%5Etfw">#AVAX</a> goes right through $65 and hits $100 sooner than expected. <a href="https://t.co/gjckaB5Kya">pic.twitter.com/gjckaB5Kya</a>
&mdash; TrendFi (@TrendFi_) <a href="https://twitter.com/TrendFi_/status/1863678882882236486?ref_src=twsrc%5Etfw">December 2, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader AMCrypto <a href="https://x.com/AMCryptoAlex/status/1863533921864155365">suggests</a> that breaking the $55 level will mark the end of a multi-year downtrend, paving the way for a strong rally as other 2021 cycle coins are also surging.
Crypto Raven <a href="https://x.com/hiRavenCrypto/status/1863850331832250477">notes</a> a 2.5x increase in Avalanche's value since the election and emphasizes its potential, citing institutional backing as a driving force.
Statistics: IntoTheBlock data shows large transaction volume increasing by 298.6% and daily active addresses growing by 23.4%. Transactions greater than $100,000 are up from 380 to 1,516 in a single day. At current price levels, 80% of AVAX holders are making profit.  
Community News: Messari's State of Avalanche Q3 report stated that Avalanche9000, the most significant update since the mainnet launch, is reducing costs and complexity for launching Layer-1s while enabling seamless liquidity flow across networks.
Avalanche has also announced Retro9000 Initiative, a $40 million gamified testnet experience encouraging developers to explore Avalanche9000 features for enhanced scalability.
Total value locked in Avalanche decentralized finance increased from $903.6 million to $1.5 billion in Q3, with transaction activity rising by 18% to 1.2 million. By the end of Q3, there were 38 different decentralized exchanges on Avalanche, adding 7 over the quarter.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42097462/dogecoin-millionaire-shares-50-million-meme-coin-strategy-for-2025-pepe-brett-are-this-bull-runs-doge-shiba-inu">&#8216;Dogecoin Millionaire&#8217; Shares $50 Million Meme Coin Strategy For 2025: Pepe, Brett Are This Bull Run&#8217;s DOGE, Shiba Inu</a></li>
</ul>
Image: Shutterstock

$AVAX

$BNB

$SOL

AVAX Surges 120% In A Month: Is Avalanche Building Up To A 'God Candle' To $100?

Craig-Hallum analyst Richard Shannon maintains Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) with a Buy and raises the price target from $38 to $75.

CRDO

Craig-Hallum Maintains Buy on Credo Technology Group, Raises Price Target to $75

<a href="https://www.medscape.com/viewarticle/ada-advises-against-using-compounded-glp-1-ra-medications-2024a1000m0u?form=fpf" title="https://www.medscape.com/viewarticle/ada-advises-against-using-compounded-glp-1-ra-medications-2024a1000m0u?form=fpf">https://www.medscape.com/viewarticle/ada-advises-against-using-compounded-glp-1-ra-medications-2024a1000m0u?form=fpf</a>

AMGN

DRIO

Hims & Hers Health, Inc. Class A Common Stock

HIMS

LFVN

TERN

VANI

VKTX

'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) with a Buy and maintains $12 price target.

HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $12 Price Target

If you're a cannabis industry worker or employer, you might not be thinking much about retirement plans, but that could and perhaps should change.
We sat down with Tyler Priest, chief revenue officer at Green Leaf Business Solutions, to explore the relevance of <a href="https://www.benzinga.com/personal-finance/24/08/40515684/labor-economist-warns-americans-get-a-failing-grade-in-retirement-security-says-the-age-of-401-k">401(k) plans</a> for the cannabis industry.
Why? Because Green Leaf just launched GreenPath 401(k), which is a significant development for the legal cannabis industry and may help reshape the conversation around <a href="https://www.benzinga.com/money/retirement-planning-guide">retirement planning</a>.
<h3 class="wp-block-heading">What Is A 401(k) And Why Should You Care?</h3>
As many US workers lucky enough to have one may already know, a 401(k) is a retirement savings plan offered by employers that allows workers to invest a portion of their paycheck to fund their retirements, often with tax advantages and a matching contribution from their employer. For workers, it's a tool for building long-term financial security.
Priest explained how such a retirement plan can be made available to cannabis industry workers. 
&#8220;We solved a series of challenges, starting with a legal structure that allowed institutional-grade 401(k) partners to be comfortable that cannabis businesses were operating within the federal and state guidelines set forth for them,&#8221; he told Benzinga.
Such plans were for the most part unavailable to cannabis employees due to regulatory difficulties, related to the way cannabis is regulated in the US. 
&#8220;Retirement planning is important for everyone,&#8221; Priest said. &#8220;The cannabis industry shouldn't be an exception. Our mission with GreenPath 401(k) is to provide employees in this sector with a stable, reliable solution to prepare for their futures.&#8221;
Read Also: <a href="https://www.benzinga.com/personal-finance/24/08/40586670/survey-finds-46-of-middle-class-workers-are-halting-or-cutting-their-retirement-contributions-du">Survey Finds 46% Of Middle-Class Workers Are Halting Or Cutting Their Retirement Contributions Due To Relentless Rise In Cost Of Living</a>
<h3 class="wp-block-heading">Overcoming Misplaced Barriers</h3>
Designing a 401(k) plan for the <a href="https://www.benzinga.com/cannabis">cannabis industry</a> was not without challenges. Regulatory concerns, such as compliance with federal guidelines like Financial Crimes Enforcement Network (FinCen), Anti-Money Laundering and the Office of Foreign Assets Control were significant hurdles.
Green Leaf Business Solutions addressed these issues by creating a robust legal and compliance framework, ensuring their plan meets federal and state requirements.
&#8220;We needed a structure that reassured institutional-grade 401(k) providers that cannabis businesses could operate within the rules,&#8221; said Priest. &#8220;This meant a meticulous compliance process and transparency at every step.&#8221;
<h3 class="wp-block-heading">Why This Matter For Employees</h3>
GreenPath 401(k) is designed with cannabis employees in mind, offering the following features 
<ul>
<li>Fiduciary-guided investment advice to make informed financial decisions.</li>
<li>Financial wellness classes on topics such as budgeting and debt consolidation.</li>
<li>Programs for car and home buying as well as credit repair resources.</li>
</ul>
These benefits are part of a broader effort to empower workers to take control of their financial futures. &#8220;It's not just about saving for retirement, it's about providing tools and knowledge to help workers manage their finances effectively,&#8221; Priest said.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h3 class="wp-block-heading">What About Employers?</h3>
Employers also stand to gain. Offering a competitive 401(k) plan can help attract and retain talent in an increasingly competitive industry. The plans offer options for employer matching contributions that can make their workplaces more appealing.
Approximately 30,000 cannabis employees are enrolled in retirement plans like GreenPath 401(k), but there's room for growth in the nearly half-a-million-workers industry.
&#8220;Attracting national institutional partners with extensive expertise has lowered financial barriers,&#8221; Priest said. &#8220;This has made it easier for both small operators and multi-state enterprises to provide these essential benefits.&#8221;
He gives credit to industry leaders, including some of the largest <a href="https://www.benzinga.com/money/multi-state-operators">multi-state operators</a> that have already adopted the program.
<h3 class="wp-block-heading">A Step Toward Stability And Legitimacy</h3>
Every 401(k) for the cannabis industry is a step toward normalizing and legitimizing the cannabis workforce, giving employees access to benefits that are standard in other industries. 
&#8220;Most businesses don't realize that if they use a smaller provider with manual processes, the potential for plan failures can be high, and the cost to a business can be hundreds of thousands, if not millions, of dollars in corrections,&#8221; noted Priest.
&#8220;We want to help employees and businesses in the cannabis industry thrive. This plan is one way we can contribute to that vision, ensuring workers have the tools they need to build a secure future.&#8221;
<ul>
<li>Read Next: <a href="https://www.benzinga.com/money/retirement-planning-guide">Retirement Planning: Guide to How and When to Start&nbsp;</a></li>
</ul>
COVER: AI generated image

Legal

EXCLUSIVE: Why Cannabis Industry Workers And Employees Should Think About 401(k) Plans

B of A Securities analyst Vivek Arya reiterates Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) with a Underperform and maintains $21 price target.

INTC

B of A Securities Reiterates Underperform on Intel, Maintains $21 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Inspire Veterinary&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>)&nbsp;stock is falling on Thursday following the <a href="https://www.nasdaq.com/press-release/inspire-veterinary-partners-announces-closing-6-million-public-offering-2024-07-10">closing of a public offering</a> for the veterinary hospital company&rsquo;s shares.



Inspire Veterinary completed a $6 million public offering for its shares yesterday. That saw the company sell 6 million shares of IVP stock at a price of $1 per share. It also offered pre-funded warrants for investors whose beneficial ownership would exceed 4.99%.



Inspire Veterinary also outlined its plans for the funds raised from this public offering. The company intends to use the money for &ldquo;working capital, general corporate purposes, payments to a third-party marketing agency for services related to marketing and advertising, strategic investments, and any additional future acquisition (if any).&rdquo;



<h2>What This Means for IVP Stock</h2>



A public offering increases the total number of outstanding shares that a company has. This also dilutes the stakes of current investors in the business. This is one of the reasons why IVP stock is falling on Thursday.



The price of the shares in the public offering was also well below the closing price of IVP stock. This is likely another reason why the company&rsquo;s shares are losing ground today.



IVP stock is down 25% as of Thursday morning. However, the company&rsquo;s shares also saw a 110.2% rally on Wednesday.



Investors will want to stick around for even more of the most recent stock market stories today!



We have all of the hottest stock market news worth reading about on Thursday! A few examples include what&rsquo;s happening with shares of Volcon&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) and Blue Star Foods&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bsfc-stock-quote/">BSFC</a>) stock, as well as the biggest pre-market stock movers this morning. All of this info is ready at the following links!



<h2>More Thursday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-volcon-vlcn-stock-up-85-today/">Why Is Volcon (VLCN) Stock Up 85% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-blue-star-foods-bsfc-stock-up-74-today/">Why Is Blue Star Foods (BSFC) Stock Up 74% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-11th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Thursday</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-inspire-veterinary-ivp-stock-down-25-today/">Why Is Inspire Veterinary (IVP) Stock Down 25% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Inspire Veterinary (IVP) Stock Down 25% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Quhuo&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/qh-stock-quote/">QH</a>) stock is sliding lower on Thursday after the gig economy platform company&rsquo;s shares underwent a recent rally.



That rally saw shares of QH stock close out Wednesday up 24.7%. That came alongside more than 2 million shares traded. To put that number in perspective, the company&rsquo;s daily average trading volume is below that at 183,000 shares. Its <a href="https://finance.yahoo.com/quote/QH/key-statistics/">float is 44.47 million units</a>.



Investors will note that QH stock rallied on Wednesday without any news from the company. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC). There also wasn&rsquo;t any analyst coverage behind the surge in price and trading.



<h2>QH Stock Movement on Thursday</h2>



Considering yesterday&rsquo;s rally happened without a clear catalyst, it makes sense that shares of QH stock would give up some of their gains. This has Quhuo&nbsp;stock down 10.5% during pre-market trading on Thursday morning.



This dip in price comes without much in the way of trading activity today. As of this writing, only about 10,000 shares of QH stock have been traded.



It&rsquo;s also worth noting that QH shares aren&rsquo;t performing well in 2024. The company&rsquo;s stock is down 63.3% year-to-date as of yesterday&rsquo;s close. It&rsquo;s also down 72.7% over the last 12 months.



Investors seeking out even more of the most recent stock market stories today will want to stick around!



We have all of the hottest stock market news that investors need to know about on Thursday! That includes all of the hottest market happenings for Inspire Veterinary&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>) stock, Volcon&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) shares and Blue Star Foods&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bsfc-stock-quote/">BSFC</a>) stock. You can catch up on all of these matters at the following links!



<h2>More Stock Market News for Thursday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-inspire-veterinary-ivp-stock-down-25-today/">Why Is Inspire Veterinary (IVP) Stock Down 25% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-volcon-vlcn-stock-up-85-today/">Why Is Volcon (VLCN) Stock Up 85% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-blue-star-foods-bsfc-stock-up-74-today/">Why Is Blue Star Foods (BSFC) Stock Up 74% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-quhuo-qh-stock-down-10-today/">Why Is Quhuo (QH) Stock Down 10% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Quhuo (QH) Stock Down 10% Today?

An update from Inspire Veterinary Partners, Inc. Class A (IVP) is now available. Kimball Carr's tenure as Chief Executive Officer has been extended...

Inspire Veterinary Partners CEO Tenure Extended, New Steering Committee Formed

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Inspire Veterinary (NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>) just reported results for the second quarter of 2024.<ul><li>Inspire Veterinary reported earnings per share of -70 cents.</li><li>The company reported revenue of $4.39 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ivp-stock-earnings-inspire-veterinary-for-q2-of-2024/">IVP Stock Earnings: Inspire Veterinary Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

IVP Stock Earnings: Inspire Veterinary Reported Results for Q2 2024

Inspire Veterinary Partners GAAP EPS of -$0.70, revenue of $4.4M

Inspire Veterinary Partners to acquire Vetsie.ai

Inspire Veterinary Partners files $100M mixed shelf offering

Inspire Veterinary stock higher as it looks to raise $2.5M through direct offering

Inspire Veterinary (IVP) Partners has entered into a securities purchase agreement with institutional investors, providing for the purchase and sal...

Inspire Veterinary to sell 10M shares at 25c in registered direct offering

Inspire Veterinary Partners GAAP EPS of -$0.38, revenue of $4.05M

BSFC

VLCN

Screenshot 2024-02-27 at 6.34.08 PM

Emerging Markets

CHWY

FRPT

More Millennials Are Opting For Pets Over Children As Pet Industry Continues To Grow

Press Releases

Inspire Veterinary Partners to Present at Sidoti Virtual Investor Conference August 14

Inspire Veterinary Partners Reaffirms Plans to Accelerate Acquisition and Growth Strategy Following Closing of Recent Public Offering

Inspire Veterinary Partners Reports Second Quarter 2024 Financial Results

Inspire Veterinary Partners Announces Phillip Balatsos as New Independent Nominee for Election to Board of Directors

Inspire Veterinary Partners Unveils Plans for New Verticals to Drive Next Phase of Growth in Veterinary Care

Inspire Veterinary Partners Announces Non-Binding Acquisition Proposal of Vetsie.ai

Inspire Veterinary Partners Announces $2.5 Million Registered Direct Offering of Common Stock

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Inspire Veterinary Partners' $2.5 Million Registered Direct Offering

Spartan Capital Securities Successfully Completes Multiple Key Transactions in October 2024

Comments

Inspire Veterinary

Inspire Veterinary (IVP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga